InvestorsObserver
×
News Home

Is Eton Pharmaceuticals Inc (ETON) a Leader in the Healthcare Sector?

Friday, April 16, 2021 11:55 AM | InvestorsObserver Analysts

Mentioned in this article

Is Eton Pharmaceuticals Inc (ETON) a Leader in the Healthcare Sector?

A rating of 84 puts Eton Pharmaceuticals Inc (ETON) near the top of the Healthcare sector according to InvestorsObserver.

Eton Pharmaceuticals Inc's score of 84 means that it ranks higher than 84% of stocks in the sector. In addition, its overall score of 70 ranks it higher than 70% of all stocks.

Overall Score - 70
ETON has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on ETON!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Eton Pharmaceuticals Inc Stock Today?

Eton Pharmaceuticals Inc (ETON) stock is down -6.07% while the S&P 500 is higher by 0.16% as of 11:23 AM on Friday, Apr 16. ETON is down -$0.52 from the previous closing price of $8.56 on volume of 140,848 shares. Over the past year the S&P 500 has gained 49.21% while ETON is higher by 103.54%. ETON lost -$1.33 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Eton Pharmaceuticals Inc (ETON) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App